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Abstract 
 
Aim:  To examine the longitudinal associations in both directions between mental health and 
substance use in adolescence.   
 
Participants and design: 3607 youth aged 11 to 16 years at baseline and followed for three 
years.   
 
Setting: Britain (nationally-representative sample).   
 
Measurements:  Externalizing and internalizing mental health problems were measured 
using brief questionnaires (parent-reported Strengths and Difficulties Questionnaire) and 
diagnostic interviews, including clinician-rated diagnoses of mental disorder.  Substance use 
was measured by youth self-report, and included regular smoking, frequent alcohol 
consumption, regular cannabis use and ever taking other illicit drugs.   
 
Findings: Externalizing (specifically behavioral) problems at baseline independently 
predicted all forms of substance use, with a particularly strong effect on smoking.  In all cases 
this association showed a dose-response relationship.  By contrast, although internalizing 
problems had a strong univariable association with smoking, this disappeared after adjusting 
for comorbid externalizing problems.  There was little or no evidence that baseline substance 
use predicted mental health at follow-up.   
 
Conclusion:  Externalizing problems predict adolescent substance use, and adjusting for 
comorbid externalizing problems is vital when investigating the effects of internalizing 
problems.  A dose-response effect of externalizing problems is seen across the full range.  
Programs seeking to prevent adolescent substance use by reducing externalizing problems 
may therefore wish to consider population-wide interventions rather than only targeting 
individuals at the negative extreme. 
 
 
 
Three citable statements: 
 In British youth, externalizing problems in early adolescence show a dose-response 
association with regular smoking, high alcohol consumption, regular cannabis use and 
lifetime illicit drug use in late adolescence.  
 Internalizing problems in early adolescence do not predict later substance use after 
adjustment for comorbid externalizing problems; such adjustment is therefore vital in 
order to avoid misleading findings.  
 Substance use in early adolescence has little or no independent predictive effect on 
mental health in late adolescence. 
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Introduction 
 
It is well-established that externalizing problems and disorders in early or middle childhood 
predict substance use, abuse and dependence in adolescence and young adulthood.  With very 
few exceptions (1), this has been shown for tobacco (2-8), cannabis (2, 6, 9-14) and other 
illicit drug use (6, 15).  This has also been shown for alcohol (6, 9, 11, 15-17), although the 
effect is often weaker and not always observed for alcohol use (as opposed to abuse) (18, 19).   
A growing body of evidence indicates that these associations are mainly driven by behavioral 
problems – hyperactivity, the other broad subgroup of externalizing problem, has little or no 
independent effect (6, 10, 16, 20). 
 
For internalizing problems (depression and anxiety) the evidence is less clear.  Interpreting 
many studies is complicated by a failure to adjust for possible comorbidity with externalizing 
problems (21-24).  Among studies which do control for comorbidity, some report 
independent effects upon substance use or dependence (1, 10, 25) while others do not or 
report only weak or inconsistent effects (7, 12, 13, 26, 27).   
 
As for the effect of substance use upon future mental health, there is relatively consistent 
evidence that smoking cigarettes or cannabis during adolescence predicts anxiety (26, 28-32), 
depression (6, 28, 33-36) and perhaps behavioral problems (29, 37) in early adult life.  
Relatively few studies, however, examine mental health outcomes within the teenage years.  
These produce more mixed results (1, 7, 37-39), including several negative or inconsistent 
findings (7, 37, 38). 
 
One complication in interpreting these findings is the focus of many studies on just one form 
of substance use.  Given the substantial co-occurrence of substance use in young people (40-
42), this complicates attempts to determine the specificity of observed relationships or 
compare magnitude of different effects.  In addition, most previous studies use only binary 
measures of disorder (e.g. 7, 15, 17) or ‘high’ questionnaire scores (e.g. 38).    Far fewer look 
for evidence of a dose-response relationship, and while some suggest such effects (6, 43) 
others do not (10).   Thus even for the well-established effect of behavioral problems upon 
future substance use, it is unclear how far this extends across the full range of oppositional, 
aggressive or antisocial behaviors in childhood.  
 
In this paper I address these gaps in the evidence using two surveys of British 11 to 16-year 
olds who were then followed for three years.  Specifically, I examine:  1) How far 
externalizing and internalizing problems at baseline predict substance use (tobacco, alcohol, 
cannabis and other illicit drugs) at follow-up; 2) How far any observed associations show a 
dose response relationship; and 3) How far substance use at baseline predicts mental health at 
follow-up.  Cross-sectional analyses of the association between substance use and mental 
health have previously been published using the baseline data for youth aged 13-15 in the 
first of the two surveys (44).  This is the first time, however, that such analyses have drawn 
on both surveys or made use of the follow-up data. 
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Methods 
 
Sample 
 
The British Child and Adolescent Mental Health Surveys (B-CAMHS) of 1999 and 2004 
were two nationally-representative surveys in England, Scotland and Wales.  Children and 
adolescents were sampled at ages 5-15 in B-CAMHS99 and 5-16 in B-CAMHS04; otherwise 
the two studies used near-identical methods for sampling and data collection (45, 46).     
 
The principal caregivers (‘parents’) of selected youth were approached for interview.  With 
parental permission, a teacher and youth aged 11 or over were also approached.  Between the 
two B-CAMHS surveys, 26_545 youth were selected and 18_415 (69.4%) participated.  This 
included 8577 youth aged 11 to 16, and therefore old enough to be interviewed about their 
substance use. 
 
Both B-CAMHS surveys included a three-year follow-up.  B-CAMHS99 oversampled 
participants with disorders at baseline (47) while B-CAMHS04 attempted to follow up all 
participants (48).  In total 5835 youth aged 11 to 16 at baseline were selected for follow-up, 
and 3739 (64.0%) participated.  Of these, 3607 youth (1124 from B-CAMHS99, 2483 from 
B-CAMHS04) provided substance use data at baseline and/or follow-up, and these represent 
the study population for this paper.  Their mean age was 13.2 years at baseline (16.2 years at 
follow-up) and 51.5% were male (12.9 years at baseline, 51.0% male in B-CAMHS99; 13.3 
years at baseline 51.7% male in B-CAMHS04). 
 
Measures 
 
Mental health 
 
Parent SDQ: All parents completed the Strengths and Difficulties Questionnaire (SDQ: 49, 
50).  The 20 items of the SDQ’s ‘total difficulty score’ provide a dimensional measure of 
common child mental health problems (51).  The total difficulty score can also be separated 
into an ‘internalizing’ subscale made up of the 10 questions on emotional and peer problems 
(range 0-20), and an ‘externalizing’ subscale made up of the 10 questions on behavioral and 
hyperactivity problems (range 0-20).  As the SDQ has only been validated for youth up to age 
16, I conduct sensitivity analyses excluding those aged 17 or more at follow-up. 
 
Probability bands from the parent DAWBA:  All parents were administered the 
Development and Well-being Assessment (DAWBA: 52, 53).  This is a detailed psychiatric 
interview administered by lay interviewers, and including both fully-structured sections and 
open-ended descriptions of problems.  Computer algorithms can use responses to the fully-
structured sections to assign ‘DAWBA bands’, these being probability bands with up to 6 
Levels which estimate the child’s probability of having a particular type of disorder.  This 
paper uses the three DAWBA bands for any internalizing disorder, any behavioral disorder 
and any hyperactivity disorder.  I use the four-Level probability bandings: Level 0/1 
(corresponding to 0.5% or below); Level 2 (around 3%); Level 3 (around 15%); and Level 
4/5 (50% or above). 
 
Clinician-rated diagnoses:  DAWBAs were also completed by teachers and youth 
participating in B-CAMHS.  Experienced child psychiatrists then used the fully-structured 
and open-ended information from all three informants to decide whether each child had a 
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mental disorder.  Diagnoses were assigned according to the Diagnostic and Statistical Manual 
of Mental Disorders, 4th edition (DSM-IV: 54); full details of all diagnoses covered by the 
DAWBA are provided in the Supporting Information.  These diagnoses have been shown to 
have good reliability and validity (52, 53), including in predicting future service use or other 
adverse outcomes (47, 48). 
 
Substance use 
 
Participating youth were asked by laptop about their substance use.  I used their responses to 
create four outcome variables: 
 Regular smoker, defined as currently smoking one or more cigarettes per week, 
following the standard definition of the UK Office for National Statistics (55).  This 
question did not give a time frame, instead asking about ‘usual’ behaviour.  When 
adjusting for baseline smoking, I used four categories: Never smoked; ex-smoker; 
occasional smoker (<1 cigarette per week), and regular smoker (≥1 cigarettes per 
week). 
 Frequent alcohol consumption, defined as being in the top 5-10% for any given age in 
a question on current drinking frequency.  This corresponded to drinking at least once 
a month at ages 11-12; once a fortnight at age 13; once a week at age 14; twice a 
week at ages 15-16; and daily at ages 17-19. This question did not give a time frame, 
instead asking about ‘usual’ behaviour.   
 Regular use of cannabis, defined as at least once a month during the past year.  When 
adjusting for baseline cannabis use, I used three categories: Never smoked cannabis in 
the last year; used cannabis less than once a month; and regular cannabis user. 
 Other illicit drug use, defined as ever using solvents; ecstasy; amphetamines; LSD; 
tranquilisers; cocaine or heroin.  
 
Potential confounders 
 
All multivariable analyses adjust for the youth’s gender; age at baseline (11-12 years, 13-14 
or 15-16); survey year (B-CAMHS99 vs. B-CAMHS04) and country (England, Scotland or 
Wales).  They also adjust for six other parent-reported youth or family characteristics, 
measured at baseline.  These are: youth’s ethnic group (White, Black, Indian, 
Pakistani/Bangladeshi, or Other); youth’s general health (Very bad, bad, fair, good, very 
good); parent’s mental health, measured by the 12-item general health questionnaire (GHQ-
12: 56) and administered by laptop; family type (two-parent, lone parent, or stepfamily); 
responding parent’s highest educational level (No qualifications, GCSEs, A-level/diploma, or 
degree); and housing tenure (owner occupier or renting). 
 
Statistical analyses 
 
Substance use data was missing at baseline or follow-up for 686 youth (19.0%); parent SDQ 
data was missing for 53 youth (1.5%); and family confounder data was missing for 16 youth 
(0.4%).  I used multiple imputation to impute missing values under an assumption of missing 
at random (57), using the MICE command in Stata10.1 (58, 59).  I used five imputations, 
including in the imputation model all explanatory and outcome variables plus the interactions 
with age and gender described below.   
 
Multivariable models used logistic regression for substance use and mental disorder 
outcomes; ordered logistic regression for the four-level DAWBA bands; and linear regression 
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for the continuous SDQ scales.  Ordered logistic regression assumes that the effect of an 
explanatory variable is the same wherever one ‘cuts’ the outcome (e.g. the odds ratio for 
levels 2-4 vs. level 1 is the same as for levels 3-4 vs. levels 1-2).  When likelihood ratio tests 
provided evidence (p<0.05) that this proportional odds assumption was violated, I instead 
present separate odds ratios for each change in level. 
 
When modelling explanatory variables, I entered the SDQ subscales and DAWBA bands as 
linear terms in order to facilitate comparisons across models.  Alternative models treating 
these as categorical variables yielded very similar substantive findings and did not suggest 
threshold or U-shaped relationships.  Potential confounders were entered as unordered 
categorical variables, except for youth’s general health and parent’s mental health which 
were entered as linear terms. All analyses adjust for the oversampling of youth with disorder 
in B-CAMHS99. 
 
To maintain a stable study population across analyses, I combined children with a disorder at 
baseline (persistent cases) and children without (incident cases).  I conducted sensitivity 
analyses stratifying by disorder presence/absence, to examine possible differences between 
the predictors of disorder persistence and disorder incidence.   
 
My focus in these analyses is upon the effect of mental health on substance use and substance 
use on mental health.  For all these associations, I tested for interactions between 1) gender 
and 2) age in the fully-adjusted models.  As this involved substantial multiple testing, I only 
report interactions significant at p<0.01.  
 
Results 
 
Table 1 describes the characteristics at baseline and follow-up of the 3607 youth in the study 
population.  Compared to all 11 to 16 year olds in the B-CAMHS baseline surveys, there was 
strong evidence that this study population contained fewer youth aged 15 or 16, fewer youth 
from minority ethnic groups, and fewer youth with high externalizing SDQ scores.  There 
was also weak evidence that youth who smoked regularly were underrepresented; for details, 
see the Supporting Information. The Supporting Information presents fuller details of the 
univariable models presented in Table 2 and the multivariable analyses in Tables 3 and 4. 
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Table 1: Demographic characteristics, mental health and substance use characteristics 
of participants at baseline and follow-up 
Variables  Baseline Follow-up 
  N†  % N†  % 
Survey year B-CAMHS99 1124 31.2% – – 
 B-CAMHS04 2483 68.8% – – 
Country England 3124 86.6% – – 
 Scotland 368 10.2% – – 
 Wales 115 3.2% – – 
Gender Male 1856 51.5% – – 
 Female 1751 48.5% – – 
Age at baseline 11 to 12 years 1378 38.2% – – 
 13 to 14 years 1360 37.7% – – 
 15 to 16 years 869 24.1% – – 
Ethnic group White 3331 92.4% – – 
 Black 59 1.6% – – 
 Indian 60 1.7% – – 
 Pakistani or 
Bangladeshi 46 1.3% 
– – 
 Other 110 3.1% – – 
Parent-reported 0 points 600 16.7% 651 18.3% 
internalizing 1-2 points 1245 34.5% 1294 36.3% 
SDQ score 3-4 points 784 21.8% 779 21.9% 
 5-6 points 447 12.4% 399 11.2% 
 7-8 points 244 6.8% 220 6.2% 
 9-11 points 191 5.3% 133 3.7% 
 12-14 points 61 1.7% 65 1.8% 
 15-20 points 32 0.9% 21 0.6% 
Parent-reported 0 points 487 13.5% 527 14.8% 
externalizing 1-2 points 915 25.4% 895 25.1% 
SDQ score 3-4 points 799 22.2% 831 23.3% 
 5-6 points 571 15.9% 538 15.1% 
 7-8 points 333 9.2% 345 9.7% 
 9-11 points 291 8.1% 269 7.6% 
 12-14 points 132 3.7% 104 2.9% 
 15-20 points 74 2.1% 52 1.5% 
Emotional disorder No 3363 93.2% 3389 94.0% 
 Yes 244 6.8% 218 6.0% 
Behavioral  disorder No 3372 93.5% 3417 94.7% 
 Yes 235 6.5% 190 5.3% 
Hyperactivity  disorder No 3522 97.6% 3571 99.0% 
 Yes 85 2.4% 36 1.0% 
Regular smoker Never 2892 85.9% 2110 66.6% 
 Ex-smoker 171 5.1% 288 9.1% 
 Occasional  111 3.3% 228 7.2% 
 Regular smoker 194 5.8% 541 17.1% 
Frequent alcohol 
consumption 
No 
3050 90.6% 2892 91.4% 
 Yes 315 9.4% 273 8.6% 
Cannabis use Never 3158 93.9% 2582 81.6% 
 Less than monthly 103 3.1% 300 9.5% 
 Monthly or more 104 3.1% 284 9.0% 
Ever used other No 3323 98.8% 2963 93.6% 
illicit drug Yes 42 1.3% 202 6.4% 
†N for some variables adds to less than 3607 due to missing data.   
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Table 2: Mental health and substance use at three-year follow-up by characteristics at 
baseline 
CHARACTERISTICS AT 
BASELINE 
CHARACTERISTICS AT FOLLOW-UP 
  Emotional 
disorder 
(%) 
Behavioral 
disorder 
(%) 
Hyperacti
vity 
disorder 
(%) 
Regular 
smoker 
(%) 
Frequent 
alcohol 
consump
tion (%) 
Regular 
cannabis 
use (%) 
Ever 
used 
other 
illicit 
drug (%) 
Full sample  5.4 4.5 0.8 17.6 8.8 9.8 6.9 
Gender Male 3.6 5.4 1.1 15.8 10.9 12.4 7.4 
 Female 7.2 3.5 0.4 19.6 6.5 7.1 6.3 
 p-value <0.001 0.01 0.01 0.008 <0.001 <0.001 0.21 
Age 11 to 12 years 3.5 5.7 1.0 8.1 8.0 5.2 2.8 
 13 to 14 years 6.7 4.0 0.7 19.4 8.9 11.1 6.2 
 15 to 16 years 6.3 3.3 0.5 29.7 9.8 15.0 14.1 
 p-value <0.001 0.01 0.47 <0.001 0.39 <0.001 <0.001 
Emotional  No 4.3 4.0 0.6 16.6 8.8 9.7 6.5 
disorder Yes 29.3 14.2 3.9 40.0 7.9 13.3 13.5 
 p-value <0.001 <0.001 <0.001 <0.001 0.66 0.14 0.005 
Behavioral No 4.9 2.9 0.4 16.0 9.3 9.1 6.5 
disorder Yes 15.6 37.6 9.5 53.5 11.6 25.8 18.7 
 p-value <0.001 <0.001 <0.001 <0.001 0.35 <0.001 <0.001 
Hyperactivity No 5.3 3.9 0.1 17.2 9.3 9.7 6.9 
disorder Yes 8.6 35.9 34.7 39.5 13.8 18.0 11.3 
 p-value 0.21 <0.001 <0.001 <0.001 0.22 0.03 0.21 
Smoking Never 4.8 4.0 0.7 10.8 8.7 6.5 4.3 
 Ex-smoker 6.9 8.1 1.6 41.4 11.8 23.2 16.2 
 Occasional  7.2 6.2 0.9 49.5 13.1 27.6 16.1 
 Regular smoker 11.7 8.2 0.5 84.2 15.8 40.0 36.4 
 p-value <0.001 0.01 0.61 <0.001 0.009 <0.001 <0.001 
Frequent 
alcohol 
No 
5.2 4.4 0.8 16.2 7.7 8.6 6.0 
consumption Yes 7.0 5.2 0.8 31.9 19.3 21.6 15.8 
 p-value 0.16 0.52 0.99 <0.001 <0.001 <0.001 <0.001 
Cannabis use Never 5.1 4.3 0.8 15.0 9.0 7.7 4.9 
 Less than monthly 6.2 6.8 1.1 43.3 11.7 32.3 24.3 
 Monthly or more 13.3 6.1 1.0 75.9 20.3 55.0 57.1 
 p-value 0.002 0.42 0.90 <0.001 0.03 <0.001 <0.001 
Ever used  No 5.2 4.4 0.8 16.9 8.7 9.3 6.2 
other illicit Yes 22.3 8.6 0.4 76.1 15.7 50.5 60.0 
drug p-value <0.001 0.18 <0.001 <0.001 0.15 <0.001 <0.001 
All p-values are for heterogeneity, from univariable logistic regression analyses.  Univariable analyses including 
the SDQ are presented in the Supporting Information. 
 
Continuity in mental health and substance use over time 
 
While not the focus of this paper, Table 2 demonstrates the striking continuity in both 
substance use and mental health over time. Multivariable analyses revealed adjusted odds 
ratios (OR) from 2 to over 10 between substance use at baseline and substance use of the 
same sort at follow-up (see Supporting Information).  The strong dose response effect of 
smoking at baseline upon smoking at follow-up was particularly notable.  There were also 
strong, dose-response effects of smoking at baseline upon regular cannabis use at follow-up, 
and of cannabis use at baseline upon having taken other illicit drugs at follow-up.   
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Mental health problems and disorders likewise showed strong continuity between baseline 
and follow-up; for example, the adjusted OR was 4.98 for internalizing disorders and 11.8 for 
behavioral disorders.  For hyperactivity, the continuity between disorder at baseline and 
disorder at follow-up was so strong (unadjusted OR 364) that it was impossible to obtain 
stable effect estimates for any baseline variable. 
 
Effect of mental health upon future substance use 
 
Table 3 presents the effect of mental health at baseline upon substance use at follow-up, 
adjusting for baseline substance use, comorbidity and family confounders.  The strongest 
effect was that youth with externalizing problems or behavioral disorders at baseline were 
more likely to be regular smokers at follow-up.  For the externalizing SDQ subscale, the OR 
for regular smoking was 1.14 (95%CI 1.10 to 1.17) per one-point increase, corresponding to 
an OR of 1.61 per standard deviation increase.  This effect was observed across the full 
range, as were the somewhat weaker associations with alcohol, cannabis, and other illicit 
drug use (see Figure 1).  Analyses using the DAWBA bands indicated that these effects were 
driven by behavioral not hyperactivity problems, and replicated the finding of a dose-
response effect (Figure 1).  This suggests that the lack of a significant effect of behavioral 
disorder upon alcohol, cannabis and other illicit drug use may reflect insufficient power to 
capture comparatively weak effects. 
 
 
Table 3: Effect of mental health at baseline upon substance use at follow-up (adjusting 
for substance use at baseline): N=3607 
   Regular 
smoker (OR 
and 95% CI) 
Frequent alcohol 
consumption (OR 
and 95% CI) 
Regular cannabis 
use (OR and 95% 
CI) 
Ever used other 
illicit drug (OR 
and 95% CI) 
Analyses 
using the 
Internalizing SDQ 
subscale 
Change per 
SDQ point 0.98 (0.94, 1.02) 0.96 (0.91, 1.02) 0.97 (0.92, 1.02) 0.95 (0.89, 1.01) 
Parent SDQ Externalizing SDQ 
subscale 
Change per 
SDQ point 
1.14 (1.10, 
1.17)*** 1.07 (1.03, 1.12)** 1.08 (1.03, 1.13)** 1.08 (1.02, 1.14)** 
       
Analyses 
using the 
Internalizing 
DAWBA band 
Change per 
level 1.08 (0.91, 1.28) 0.93 (0.75, 1.16) 1.02 (0.82, 1.28) 0.95 (0.72, 1.25) 
DAWBA 
probability 
bands 
Behavioral 
DAWBA band 
Change per 
level 1.48 (1.23, 
1.78)*** 1.29 (1.03, 1.63)* 1.37 (1.12, 1.68)** 1.32 (1.00, 1.74)* 
 Hyperactivity 
DAWBA band 
Change per 
level 1.16 (0.93, 1.44) 0.96 (0.74, 1.25) 0.92 (0.73, 1.18) 0.99 (0.72, 1.36) 
       
Analyses Internalizing No 1* 1 1 1 
using  disorder Yes 1.65 (1.08, 2.52) 1.01 (0.52, 1.95) 1.01 (0.57, 1.81) 1.37 (0.72, 2.58) 
clinical Behavioral No 1*** 1 1 1 
diagnoses disorder Yes 2.83 (1.72, 4.64) 1.00 (0.55, 1.82) 1.66 (0.97, 2.84) 1.63 (0.83, 3.22) 
 Hyperactivity No 1 1 1 1 
 disorder Yes 1.25 (0.55, 2.82) 1.37 (0.61, 3.10) 0.87 (0.37, 2.07) 0.79 (0.26, 2.36) 
OR = odds ratio.  All models adjust for gender; age; baseline smoking, alcohol use, cannabis use and other illicit 
drug use; survey year; country; ethnic group; parent education; housing tenure; family type.  For full results of 
the models using the SDQ and clinical diagnoses, see Supporting Information.
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Figure 1: Adjusted odds ratio of substance use at follow-up by externalizing SDQ 
score at baseline 
 
Odds ratios adjusted for baseline internalizing SDQ score, plus gender, age, baseline smoking, alcohol use, 
cannabis use and other illicit drug use, survey year, country, ethnic group, general health, parent mental 
health, family type, parent education, housing tenure.  The models are therefore identical to those presented 
in Table 3, except that externalizing SDQ subscale was entered as a categorical variable rather than as a 
continuous term.   
 
Figure 2: Adjusted odds ratio of substance use at follow-up by parent DAWBA 
bands 
 
Odds ratios adjusted for other DAWBA bands, plus gender, age, baseline smoking, alcohol use, cannabis 
use and other illicit drug use, survey year, country, ethnic group, general health, parent mental health, 
family type, parent education, housing tenure.  The models are therefore identical to those presented in 
Table 3, except that the DAWBA bands are entered as a categorical variables rather than continuous terms.   
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Figure 3: Adjusted odds ratio of regular smoking at follow-up by internalizing SDQ 
score with and without adjustment for externalizing SDQ score 
 
p-values presented are for heterogeneity for the internalizing SDQ subscale/DAWBA band.  Adjusted 
models adjust for externalizing SDQ score/the behavioral and hyperactivity DAWBA bands as linear terms. 
 
 
By contrast, there was no convincing evidence that internalizing problems or disorders 
predicted alcohol, cannabis or other illicit drug use.  In univariable analyses, there was 
strong evidence (p<0.001) that the internalizing SDQ subscale and DAWBA band 
predicted smoking at follow-up.  This disappeared entirely, however, after adjusting for 
externalizing problems (Figure 3).  The continued weak evidence (p=0.02) for an effect 
of internalizing disorder upon future smoking therefore seems likely to reflect residual 
confounding, caused by adjusting only for the relatively crude binary measures of 
behavioral or hyperactivity  disorder.  
 
Effect of substance use upon future mental health 
 
Table 4 presents the effect of substance use at baseline upon mental health at follow-up, 
adjusting for substance use, comorbidity and family confounders at baseline.  There was 
some evidence that other illicit drug use predicted internalizing problems or disorders.  
This effect was seen across all three internalizing outcomes; nevertheless in the context 
of multiple testing this weakly-significant finding should be interpreted with caution as it 
may represent a chance result.  In no other case was there any evidence of an effect of 
substance use at baseline upon mental health at follow-up (p>0.15). 
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Table 4: Effect of substance use at baseline upon mental health at follow-up (adjusting for mental health at baseline): N=3607 
  Analyses using the parent SDQ Analyses using the DAWBA probability bands Analyses using clinical diagnoses 
  Internalizing 
SDQ subscale 
(regression 
coefficient & 
95%CI) 
Externalizing SDQ 
subscale (regression 
coefficient & 
95%CI)  
Internalizing 
DAWBA band (OR 
and 95% CI) 
Behavioral 
DAWBA band 
(OR and 95% CI) 
Hyperactivity 
DAWBA band 
(OR and 95% CI) 
Internalizing 
disorder (OR and 
95% CI) 
Behavioral 
disorder (OR and 
95% CI) 
Smoking Never 0 0 1 1 1 1 1 
 Ex-smoker -0.13 (-0.50, 0.24) 0.15 (-0.36, 0.65) 0.80 (0.52, 1.25) -0.01 (-0.18, 0.16) -0.11 (-0.35, 0.14) 0.88 (0.43, 1.79) 1.84 (0.88, 3.83) 
 Occasional 0.04 (-0.39, 0.47) -0.16 (-0.75, 0.44) 1.34 (0.81, 2.22) 0.02 (-0.21, 0.25) 0.09 (-0.18, 0.36) 1.18 (0.49, 2.84) 1.74 (0.60, 5.08) 
 Regular smoker -0.17 (-0.67, 0.33) -0.01 (-0.64, 0.61) 0.95 (0.59, 1.54) 0.07 (-0.13, 0.27) 0.15 (-0.07, 0.37) 0.77 (0.36, 1.64) 0.83 (0.32, 2.14) 
Frequent alcohol No 0 0 1 1 1 1 1 
consumption Yes -0.15 (-0.41, 0.12) 0.16 (-0.18, 0.50) 0.95 (0.68, 1.33) 0.09 (-0.04, 0.22) -0.07 (-0.26, 0.12) 1.40 (0.85, 2.31) 1.06 (0.55, 2.05) 
Cannabis use  Never 0 0 1 1 1 1 1 
 Less than monthly 0.31 (-0.20, 0.82) -0.08 (-0.69, 0.54) 1.18 (0.69, 2.03) 0.13 (-0.10, 0.36) -0.04 (-0.37, 0.29) 0.75 (0.30, 1.92) 1.26 (0.38, 4.16) 
 Monthly or more 0.32 (-0.36, 1.00) -0.26 (-1.10, 0.59) 1.34 (0.73, 2.46) -0.13 (-0.42, 0.16) -0.09 (-0.39, 0.21) 1.00 (0.37, 2.67) 0.65 (0.17, 2.52) 
Ever used other No 
0* 0 
Non-proportional odds 
(p<0.001) 1 1 1* 1 
illicit drug Yes 
1.12 (0.04, 2.21) 0.43 (-0.89, 1.75) 
≤ L1 vs. L2+:     
   1.49 (0.57, 3.91) -0.05 (-0.40, 0.30) 0.17 (-0.18, 0.52) 4.06 (1.31, 12.56) 1.31 (0.26, 6.65) 
  
  
≤L2 vs. L3+:   
  3.88 (1.30,11.55)*     
  
  
≤L3 vs. L4+:  
10.61 (2.17, 51.8)**     
L1=DAWBA probability band Level 1; L2=Level 2; L3=Level 3; L4=Level4.  Level-specific odds ratios presented for the effect of  illicit drug use at baseline upon 
internalising DAWBA band at follow-up because of strong evidence(p<0.001) that the proportional odds assumption was not met.  OR = odds ratio, calculated using 
logistic regression for clinical diagnoses and ordered logistic regression for the DAWBA bands.  Results not presented for hyperactivity disorder at follow-up because 
very high collinearity with hyperactivity at baseline led to very unstable estimates.  All models adjust for gender; age; baseline internalizing and externalizing mental 
health problems/disorders (using the same mental health measure as the outcome); survey year; country; ethnic group; parent education; housing tenure; family type. For 
full results of the models using the SDQ and clinical diagnoses, see Supporting Information.  The Supporting Information also presents separately the predictors of mental 
disorder persistence and mental disorder incidence. 
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Interactions and sensitivity analyses 
 
None of the associations in Tables 3 and 4 showed evidence of an interaction with age or 
gender (p<0.01).  The point estimates and substantive findings were very similar in 
sensitivity analyses using complete case analyses of those with no missing data (N=2890), or 
after restricting the SDQ analyses to those aged 13-16 at follow-up (N=2081).  The predictors 
of regular smoking and regular cannabis use at follow-up were very similar to the predictors 
of lifetime smoking/cannabis use (see Supporting information).  The predictors of mental 
disorder at follow-up were very similar between children with a disorder at baseline and those 
without, with no evidence of an interaction between presence/absence of baseline disorder 
and any substance use variable (p>0.15; see Supporting information).   
 
Discussion 
 
In this sample of 3607 British youth aged 11 to 16, there was strong evidence that 
externalizing problems or disorders at baseline predicted smoking, alcohol, cannabis and 
other illicit drug use at three-year follow-up.  This association was particularly strong for 
smoking, and was carried by behavioral problems; hyperactivity problems and disorders 
showed no independent effects.  For all forms of substance use, externalizing/behavioral 
problems showed a dose-response relationship across the whole range.  By contrast, there 
was little or no evidence of any independent effect of internalizing problems or disorders at 
baseline.  Instead the strong univariable effects of internalizing problems upon smoking 
largely disappeared after adjusting for comorbid externalizing problems.  There was also little 
evidence for independent effects of substance use at baseline upon mental health at follow-
up.  The only exception was that taking other illicit drugs increased the risk of internalizing 
problems and disorders.   
 
In interpreting these findings, it is worth remembering this paper’s limitations.  The reliance 
on self-reported substance use could lead to information biases (e.g. over- or under-reporting 
by youth with mental health problems); future studies using objective measures such as saliva 
cotinine concentrations would be valuable to address this possibility.  The substance use 
information in this study was also limited in including no information on substance abuse or 
dependence, which may have different predictors to substance use (3, 23, 25).  The mental 
health data was substantially richer, but some analyses using the rare, binary ‘mental 
disorder’ outcomes may have lacked power.  This plausibly explained the failure to detect 
modest effects of behavioural disorder upon alcohol, cannabis and drug use.  The lack of 
evidence of any difference in the predictors of disorder persistence and disorder incidence 
should likewise be treated with caution, as this study was not well-powered to examine this 
issue.  Finally, although the onset of behavioral problems prior to substance use is consistent 
with a causal relationship, it may also reflect the operation of unmeasured confounders.  In 
particular, this study cannot address the substantial role of shared genetic liability (39). 
 
Yet although it cannot address the possibility of genetic confounding, this paper makes some 
novel contributions to our understanding of externalizing problems as predictors of substance 
use in adolescence.  One is the demonstration that this effect of behavioral problems applies 
across the whole range.  The Christchurch Health and Development Study has previously 
reported that behavioral problems at age 7-9 had a dose response effect upon nicotine and 
illicit drug dependence at ages 21-25, even after adjustment for multiple confounders 
{Fergusson, 2005 #1305}.  The Christchurch Study has also demonstrated a univariable dose 
response association between these childhood behavioural problems and tobacco, cannabis 
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and other illicit drug use at age 18 (but no association with alcohol use) (6).  To my 
knowledge, however, this is the first paper to show that dose response effects upon adolescent 
substance use persist even in multivariable analyses which adjust for multiple youth and 
family factors, including baseline substance use and comorbidity.  This matters because 
several commentators have suggested the need for strategies to prevent teen smoking or 
drinking that focus on youth with marked behavioral problems (e.g. 7, 16).  Yet if behavioral 
problems have an effect across the full range, then population-wide interventions which 
attempt to shift the distribution of the whole population may have more impact than 
interventions which target individuals at the extremes (60). 
 
The B-CAMHS data also provides a dramatic illustration of why it is vital to adjust for 
comorbid externalizing problems when interpreting the effects of internalizing problems upon 
substance use.  The dimensional and ordered mental health measures showed strong and 
highly significant univariable effects of internalizing problems, but these completely 
disappeared after adjusting for externalizing problems.  By contrast, weakly significant 
effects remained for the clinical diagnosis of mental disorder, probably as a result of residual 
confounding.  This both confirms the importance of adjusting for externalizing problems (61) 
and also warns against assuming that binary measures of disorder are adequate in this regard.  
Residual confounding may partly explain why some studies using binary measures of 
disorder report independent effects of internalizing problems (1, 10, 25), while a larger 
number do not (7, 12, 13, 26, 27).  This study adds to the evidence of the latter studies, 
indicating that internalizing problems do not have an independent effect upon substance use 
in mid to late adolescence.  This contrasts with findings in young adults (2, 34, 62, 63), 
highlighting the need to consider how the effects of different types of mental health problems 
may vary at different stages of development (7){Hayatbakhsh, 2008 #1299}.   
 
Also in contrast with findings from young adults (6, 26, 28-37) is the finding of this study 
that most forms of substance use do not predict mental health problems in adolescence.  This 
is in line with some previous studies that examine mental health within adolescence (7, 37), 
and again indicates the possibility of differential effects at different stages of development.  
The one possible exception was some evidence of an increased risk of internalizing problems 
or disorders for youth who reported ever having taken a non-cannabis illicit drug at baseline.  
In the context of multiple testing this weakly-significant finding should be treated with some 
caution; nevertheless, it does replicate another recent British study which found that having 
tried drugs predicted depressive symptoms at two-year follow-up (38).  Finally, this paper 
also replicated previous reports of co-occurrence of substance use, of strong continuity in 
substance use over time (40-42, 64), and of cross-substance effects of smoking upon cannabis 
use, and cannabis use upon other drugs (1, 64-67). 
 
In conclusion, this paper adds further evidence that the most consistent longitudinal 
association between substance use and mental health in adolescence is one in which earlier 
behavioral problems predict later substance use.  It further indicates that these effects were 
strongest upon smoking in this British sample, and showed a dose response effect across the 
full range.  At least one randomised controlled trial has shown modest success in reducing 
smoking initiation through a universal intervention designed to prevent externalizing and 
other mental health problems in first grade children (68, 69).  This paper strengthens the 
evidence-base for pursuing population-wide prevention programs of this sort.  
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SUPPORTING INFORMATION 
Box 1:  Common child mental disorders covered by the DAWBA, assigned according to 
the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSV-IV) 
 
Internalizing disorders 
 
Anxiety disorders 
 Separation anxiety 
 Specific phobia 
 Social phobia 
 Panic attacks 
 Agoraphobia 
 Post Traumatic Stress Disorder 
 Obsessive-Compulsive Disorder 
 Generalised Anxiety Disorder 
 Anxiety disorder, not otherwise specified 
 
Depression 
 Depressive episode 
 Depressive episode, not otherwise specified. 
 
Behavioural disorders (sometimes grouped with hyperactivity and called ‘externalizing’ 
disorders) 
 Oppositional defiant disorder 
 Conduct disorder 
 Disruptive Behaviour Disorder, not otherwise specified. 
 
Hyperactivity (sometimes grouped with behavioural problems and called ‘externalizing’ 
disorders) 
 Attention Deficit Hyperactive Disorder (ADHD) Combined Type 
 ADHD Inattentive Type 
 ADHD Hyperactive-Impulsive Type 
 Hyperactive disorder, not otherwise specified 
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Table 5: Comparison of youth in study population compared to all 11 to 16 year olds 
selected for follow-up 
Variables  All 11 to 16 year 
olds selected for 
follow-up, N† (%) 
Study population 
for analyses N† 
(%) 
Odds ratio & 
95%CI for being in 
the study population 
Survey year B-CAMHS99 1783 (30.6%) 1124 (31.2%) 1 
 B-CAMHS04 4052 (69.4%) 2483 (68.8%) 1.08 (0.93, 1.25) 
Country England 5067 (86.8%) 3124 (86.6%) 1 
 Scotland 552 (9.5%) 368 (10.2%) 1.18 (0.91, 1.52) 
 Wales 216 (3.7%) 115 (3.2%) 0.83 (0.60, 1.15) 
Gender Male 3033 (52.0%) 1856 (51.5%) 1 
 Female 2802 (48.0%) 1751 (48.5%) 1.00 (0.88, 1.14) 
Age at baseline 11 to 12 years 2127 (36.5%) 1378 (38.2%) 1*** 
 13 to 14 years 2074 (35.5%) 1360 (37.7%) 1.05 (0.89, 1.23) 
 15 to 16 years 1634 (28.0%) 869 (24.1%) 0.72 (0.61, 0.85) 
Ethnic group White 5203 (89.2%) 3331 (92.4%) 1*** 
 Black 138 (2.4%) 59 (1.6%) 0.36 (0.25, 0.50) 
 Indian 130 (2.2%) 60 (1.7%) 0.47 (0.32, 0.71) 
 Pakistani or 
Bangladeshi 162 (2.8%) 46 (1.3%) 0.24 (0.16, 0.36) 
 Other 201 (3.5%) 110 (3.1%) 0.72 (0.53, 0.98) 
Parent-reported 0 points 923 (15.9%) 600 (16.7%) 1 
internalizing 1-2 points 1896 (32.7%) 1245 (34.5%) 1.06 (0.88, 1.29) 
SDQ score 3-4 points 1254 (21.7%) 784 (21.8%) 1.03 (0.84, 1.26) 
 5-6 points 752 (13.0%) 447 (12.4%) 0.97 (0.76, 1.25) 
 7-8 points 423 (7.3%) 244 (6.8%) 1.06 (0.80, 1.39) 
 9-11 points 355 (6.1%) 191 (5.3%) 0.93 (0.69, 1.27) 
 12-14 points 124 (2.1%) 61 (1.7%) 0.86 (0.56, 1.33) 
 15-20 points 64 (1.1%) 32 (0.9%) 0.89 (0.45, 1.73) 
Parent-reported 0 points 698 (12.1%) 487 (13.5%) 1*** 
externalizing 1-2 points 1337 (23.1%) 915 (25.4%) 0.94 (0.73, 1.20) 
SDQ score 3-4 points 1233 (21.3%) 799 (22.2%) 0.78 (0.61, 1.00) 
 5-6 points 938 (16.2%) 571 (15.9%) 0.73 (0.57, 0.93) 
 7-8 points 601 (10.4%) 333 (9.2%) 0.61 (0.46, 0.80) 
 9-11 points 542 (9.4%) 291 (8.1%) 0.55 (0.41, 0.73) 
 12-14 points 287 (5.0%) 132 (3.7%) 0.43 (0.31, 0.62) 
 15-20 points 148 (2.6%) 74 (2.1%) 0.71 (0.45, 1.13) 
Regular smoker Never 4202 (83.7%) 2892 (85.9%) 1* 
 Ex-smoker 286 (5.7%) 171 (5.1%) 0.78 (0.59, 1.03) 
 Occasional  160 (3.2%) 111 (3.3%) 1.20 (0.83, 1.73) 
 Regular smoker 370 (7.4%) 194 (5.8%) 0.72 (0.53, 0.96) 
Frequent alcohol 
consumption 
No 
4552 (90.8%) 3050 (90.6%) 1 
 Yes 461 (9.2%) 315 (9.4%) 1.22 (0.98, 1.51) 
Cannabis use Never 4638 (92.5%) 3158 (93.9%) 1 
 Less than monthly 178 (3.6%) 103 (3.1%) 0.82 (0.57, 1.19) 
 Monthly or more 196 (3.9%) 104 (3.1%) 0.84 (0.56, 1.25) 
Ever used other No 4930 (98.4%) 3323 (98.8%) 1 
illicit drug Yes 82 (1.6%) 42 (1.3%) 0.89 (0.54, 1.47) 
†Missing data means that N sometimes adds to less than 5835 (for column 1) or 3607 (for column 2) due to 
missing data.   
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Table 6: Mental health and substance use at three-year follow-up by characteristics at baseline: full results including the SDQ subscales 
CHARACTERISTICS AT 
BASELINE 
CHARACTERISTICS AT FOLLOW-UP 
 
  Internalizing 
SDQ (mean)  
Externalizin
g SDQ 
(mean) 
Emotional 
disorder 
(%) 
Behavioral 
disorder 
(%) 
Hyperacti
vity 
disorder 
(%) 
Regular 
smoker 
(%) 
Frequent 
alcohol 
consumption 
(%) 
Regular 
cannabis 
use (%) 
Ever used 
other illicit 
drug (%) 
Full sample  2.9 3.9 5.4 4.5 0.8 17.6 8.8 9.8 6.9 
Gender Male 2.7 4.4 3.6 5.4 1.1 15.8 10.9 12.4 7.4 
 Female 3.2 3.5 7.2 3.5 0.4 19.6 6.5 7.1 6.3 
 p-value[a] <0.001 <0.001 <0.001 0.01 0.01 0.008 <0.001 <0.001 0.21 
 R-squared 0.007 0.02 0.02 0.008 0.02 0.004 0.01 0.01 <0.001 
Age 11 to 12 years 2.9 4.2 3.5 5.7 1.0 8.1 8.0 5.2 2.8 
 13 to 14 years 3.0 4.0 6.7 4.0 0.7 19.4 8.9 11.1 6.2 
 15 to 16 years 2.9 3.5 6.3 3.3 0.5 29.7 9.8 15.0 14.1 
 p-value[a] 0.57 <0.001 <0.001 0.01 0.47 <0.001 0.39 <0.001 <0.001 
 R-squared 0.0001 0.007 0.02 0.008 0.01 0.05 0.004 0.02 0.05 
Parent 0 points 1.2 2.8 1.5 2.0 0.2 16.5 10.4 11.0 7.5 
internalizing  1-2 points 2.0 3.3 2.9 2.9 0.1 14.8 9.7 9.7 6.7 
SDQ subscale 3-4 points 2.9 3.9 4.8 2.5 0.4 17.5 8.6 8.5 7.7 
 5-6 points 4.2 5.1 7.2 7.9 1.2 18.3 10.3 9.1 6.7 
 7-8 points 5.4 5.4 12.5 9.4 2.1 25.5 8.5 12.6 5.9 
 9-11 points 6.7 5.9 16.9 11.4 2.0 25.3 6.7 11.0 7.8 
 12-14 points 8.4 8.4 26.2 18.3 11.3 34.3 11.7 12.0 4.8 
 15-20 points 9.5 8.0 24.9 24.1 11.9 25.0 2.3 8.6 6.7 
 p-value[b] <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.18 0.55 0.78 
 R-squared 0.35 0.12 0.09 0.08 0.14 0.01 0.002 <0.001 <0.001 
Parent  0 points 2.0 1.1 2.2 0.5 0.0 6.6 5.0 5.3 3.6 
externalizing  1-2 points 2.3 2.3 5.2 1.0 0.0 11.4 9.0 7.1 5.8 
SDQ subscale 3-4 points 2.7 3.4 4.1 1.8 0.0 15.3 8.8 9.1 5.7 
 5-6 points 3.1 4.9 5.0 3.6 0.0 21.7 10.6 11.2 8.5 
 7-8 points 3.7 6.0 7.2 6.2 1.1 27.3 11.5 12.3 10.6 
 9-11 points 4.2 7.8 6.5 13.4 2.5 28.1 13.1 14.8 9.3 
 12-14 points 5.5 9.5 16.6 25.2 8.9 41.0 12.2 24.9 15.6 
 15-20 points 6.8 11.7 18.3 51.3 13.2 54.2 14.0 23.4 12.2 
 p-value[b] <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
 R-squared 0.11 0.48 0.03 0.25 0.33 0.07 0.009 0.03 0.02 
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Emotional  No 2.8 3.8 4.3 4.0 0.6 16.6 8.8 9.7 6.5 
disorder Yes 6.3 6.3 29.3 14.2 3.9 40.0 7.9 13.3 13.5 
 p-value[a] <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.66 0.14 0.005 
 R-squared 0.08 0.03 0.08 0.02 0.02 0.02 <0.001 0.001 0.005 
Behavioral No 2.8 3.7 4.9 2.9 0.4 16.0 9.3 9.1 6.5 
disorder Yes 5.5 9.2 15.6 37.6 9.5 53.5 11.6 25.8 18.7 
 p-value[a] <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.35 <0.001 <0.001 
 R-squared 0.05 0.14 0.02 0.18 0.19 0.04 <0.001 0.02 0.02 
Hyperactivity No 2.9 3.8 5.3 3.9 0.1 17.2 9.3 9.7 6.9 
disorder Yes 6.2 10.4 8.6 35.9 34.7 39.5 13.8 18.0 11.3 
 p-value[a] <0.001 <0.001 0.21 <0.001 <0.001 <0.001 0.22 0.03 0.21 
 R-squared 0.02 0.08 0.009 0.06 0.48 0.004 0.004 0.003 0.003 
Smoking Never 2.8 3.8 4.8 4.0 0.7 10.8 8.7 6.5 4.3 
 Ex-smoker 3.2 4.9 6.9 8.1 1.6 41.4 11.8 23.2 16.2 
 Occasional  3.1 4.1 7.2 6.2 0.9 49.5 13.1 27.6 16.1 
 Regular smoker 3.9 5.8 11.7 8.2 0.5 84.2 15.8 40.0 36.4 
 p-value[a] <0.001 <0.001 <0.001 0.01 0.61 <0.001 0.009 <0.001 <0.001 
 R-squared 0.007 0.02 0.01 0.01 0.009 0.19 0.009 0.09 0.12 
Frequent alcohol No 2.9 3.9 5.2 4.4 0.8 16.2 7.7 8.6 6.0 
consumption Yes 2.8 4.7 7.0 5.2 0.8 31.9 19.3 21.6 15.8 
 p-value[a] 0.45 0.001 0.16 0.52 0.99 <0.001 <0.001 <0.001 <0.001 
 R-squared 0.0001 0.005 0.002 0.004 <0.001 0.01 0.02 0.02 0.02 
Cannabis use Never 2.9 3.9 5.1 4.3 0.8 15.0 9.0 7.7 4.9 
 Less than monthly 3.2 4.4 6.2 6.8 1.1 43.3 11.7 32.3 24.3 
 Monthly or more 3.7 5.0 13.3 6.1 1.0 75.9 20.3 55.0 57.1 
 p-value[a] 0.03 0.02 0.002 0.42 0.90 <0.001 0.03 <0.001 <0.001 
 R-squared 0.002 0.003 0.01 0.001 0.003 0.06 0.008 0.08 0.12 
Ever used other No 2.9 3.9 5.2 4.4 0.8 16.9 8.7 9.3 6.2 
illicit drug Yes 
4.6 5.6 22.3 8.6 
[empty 
cell] 76.1 15.7 50.5 60.0 
 p-value[a] 0.006 0.02 <0.001 0.18 0.59 <0.001 0.15 <0.001 <0.001 
 R-squared 0.005 0.003 0.01 0.002 - 0.03 0.001 0.03 0.06 
 [a] P-value for heterogeneity; [b] p-value for linear trend.  P-values and R-squared  from univariable regression analyses, using linear regression analyses and R-squared 
values for SDQ subscales, and logistic regression and pseudo R-squared values for mental disorders and substance use outcomes.  The only exception was for illicit drug use 
at baseline and hyperactivity disorder at follow-up, where the empty cell meant that I used an exact Fisher’s chi-squared test. 
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Table 7: Predicting to substance use at follow-up, using parent SDQ scores: full results 
  Regular smoker 
(OR and 95% CI) 
Frequent alcohol 
consumption (OR 
and 95% CI) 
Regular cannabis 
use (OR and 95% 
CI) 
Ever used other 
illicit drug (OR 
and 95% CI) 
Gender Male 1*** 1** 1*** 1 
 Female 1.40 (1.09, 1.79) 0.64 (0.47, 0.87) 0.53 (0.39, 0.72) 0.91 (0.64, 1.30) 
Age at baseline 11 to 12 years 1*** 1 1** 1* 
 13 to 14 years 2.17 (1.61, 2.91) 1.26 (0.91, 1.76) 1.87 (1.30, 2.69) 1.70 (1.03, 2.81) 
 15 to 16 years 2.42 (1.70, 3.45) 1.38 (0.91, 2.10) 1.72 (1.12, 2.66) 2.54 (1.44, 4.48) 
Internalizing SDQ 
subscale 
Change per SDQ 
point 0.98 (0.94, 1.02) 0.96 (0.91, 1.02) 0.97 (0.92, 1.02) 0.95 (0.89, 1.01) 
Externalizing SDQ 
subscale 
Change per SDQ 
point 
1.14 (1.10, 
1.17)*** 1.07 (1.03, 1.12)** 1.08 (1.03, 1.13)** 1.08 (1.02, 1.14)** 
Smoking Never 1*** 1 1*** 1* 
 Ex-smoker 3.27 (2.16, 4.95) 1.18 (0.62, 2.25) 2.66 (1.56, 4.54) 2.12 (1.08, 4.17) 
 Occasional 5.12 (3.06, 8.59) 1.03 (0.51, 2.08) 3.02 (1.50, 6.06) 1.82 (0.82, 4.05) 
 Regular smoker 16.88 (9.60, 29.70) 1.19 (0.59, 2.38) 3.46 (1.87, 6.38) 2.41 (1.14, 5.08) 
Frequent alcohol No 1 1** 1 1 
consumption Yes 1.16 (0.78, 1.71) 1.92 (1.29, 2.86) 1.43 (0.96, 2.14) 1.24 (0.73, 2.09) 
Cannabis use  Never 1 1 1** 1*** 
 Less than monthly 0.92 (0.46, 1.85) 0.87 (0.36, 2.13) 2.14 (1.16, 3.96) 2.23 (1.08, 4.60) 
 Monthly or more 1.47 (0.67, 3.21) 1.59 (0.68, 3.75) 3.93 (2.05, 7.54) 6.05 (3.07, 11.91) 
Ever used other No 1 1 1 1** 
illicit drug Yes 2.28 (0.75, 6.91) 0.82 (0.27, 2.44) 1.42 (0.60, 3.37) 3.60 (1.39, 9.34) 
Survey year B-CAMHS99 1 1* 1** 1 
 B-CAMHS04 1.00 (0.76, 1.32) 0.72 (0.53, 0.98) 0.58 (0.43, 0.79) 1.08 (0.71, 1.66) 
Country England 1 1 1 1 
 Scotland 0.93 (0.58, 1.48) 0.70 (0.42, 1.18) 0.99 (0.65, 1.52) 0.80 (0.41, 1.56) 
 Wales 1.17 (0.67, 2.05) 0.50 (0.16, 1.64) 0.78 (0.31, 1.99) 1.14 (0.43, 3.03) 
Ethnic group White 1* 1** 1 1 
 Black 0.09 (0.01, 0.74) 0.14 (0.02, 1.07) 1.44 (0.49, 4.20) 0.45 (0.05, 4.40) 
 Indian† 0.17 (0.02, 1.43)  0.63 (0.12, 3.17)  
 Pakistani or 
Bangladeshi† 0.63 (0.14, 2.82)  0.18 (0.02, 1.73)  
 Other 0.63 (0.25, 1.61) 0.22 (0.07, 0.74) 0.89 (0.36, 2.16) 0.76 (0.29, 1.98) 
Good general 
health 
Change per level 
0.99 (0.82, 1.20) 1.15 (0.88, 1.50) 1.13 (0.87, 1.46) 1.09 (0.80, 1.48) 
Parent mental 
health 
Change per point 
1.02 (0.98, 1.06) 0.99 (0.94, 1.05) 0.99 (0.94, 1.04) 1.02 (0.95, 1.08) 
Family type Two-parent  1*** 1 1 1 
 Lone parent  1.78 (1.23, 2.57) 1.09 (0.70, 1.70) 1.44 (0.95, 2.19) 1.22 (0.77, 1.95) 
 Step family 1.94 (1.43, 2.64) 1.06 (0.71, 1.57) 1.14 (0.78, 1.67) 1.16 (0.73, 1.84) 
Parent’s highest No qualifications 1 1 1 1 
educational GCSEs 0.98 (0.71, 1.36) 1.13 (0.75, 1.68) 1.02 (0.70, 1.51) 0.85 (0.52, 1.39) 
level A-levels/diploma 0.92 (0.64, 1.32) 1.21 (0.77, 1.90) 1.20 (0.77, 1.86) 0.83 (0.47, 1.49) 
 Degree 0.85 (0.54, 1.34) 1.42 (0.85, 2.36) 1.58 (0.98, 2.55) 1.22 (0.64, 2.32) 
Housing tenure Owner occupied 1 1** 1 1 
 Rented 1.12 (0.82, 1.53) 0.48 (0.30, 0.77) 1.04 (0.72, 1.49) 0.73 (0.43, 1.24) 
OR = odds ratio.  † No Indian, Pakistani or Bangladeshi youth reported frequent alcohol use or other illicit drug 
use at follow-up, and these groups were therefore combined with youth of Other ethnicity when fitting 
multivariable models. 
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Table 8: Predicting to substance use at follow-up, using clinical diagnoses: full results 
  Regular smoker 
(OR and 95% CI) 
Frequent alcohol 
consumption (OR 
and 95% CI) 
Regular cannabis 
use (OR and 95% 
CI) 
Ever used other 
illicit drug (OR 
and 95% CI) 
Gender Male 1 1** 1*** 1 
 Female 1.22 (0.96, 1.54) 0.59 (0.43, 0.80) 0.49 (0.36, 0.66) 0.83 (0.58, 1.18) 
Age at baseline 11 to 12 years 1*** 1 1** 1* 
 13 to 14 years 2.07 (1.53, 2.78) 1.23 (0.88, 1.71) 1.81 (1.26, 2.61) 1.67 (1.01, 2.76) 
 15 to 16 years 2.10 (1.48, 2.98) 1.27 (0.84, 1.93) 1.58 (1.02, 2.44) 2.38 (1.35, 4.18) 
Emotional No 1* 1 1 1 
disorder Yes 1.65 (1.08, 2.52) 1.01 (0.52, 1.95) 1.01 (0.57, 1.81) 1.37 (0.72, 2.58) 
Behavioral No 1*** 1 1 1 
disorder Yes 2.83 (1.72, 4.64) 1.00 (0.55, 1.82) 1.66 (0.97, 2.84) 1.63 (0.83, 3.22) 
Hyperactivity No 1 1 1 1 
disorder Yes 1.25 (0.55, 2.82) 1.37 (0.61, 3.10) 0.87 (0.37, 2.07) 0.79 (0.26, 2.36) 
Smoking Never 1*** 1 1*** 1* 
 Ex-smoker 3.65 (2.44, 5.46) 1.29 (0.67, 2.47) 2.94 (1.74, 4.99) 2.29 (1.18, 4.47) 
 Occasional 5.81 (3.46, 9.76) 1.13 (0.55, 2.32) 3.30 (1.64, 6.64) 1.98 (0.88, 4.45) 
 Regular smoker 19.65 (11.28, 34.22) 1.50 (0.75, 2.99) 3.97 (2.15, 7.33) 2.68 (1.30, 5.54) 
Frequent alcohol No 1 1** 1 1 
consumption Yes 1.20 (0.81, 1.78) 1.99 (1.33, 2.96) 1.48 (0.99, 2.21) 1.29 (0.77, 2.18) 
Cannabis use  Never 1 1 1** 1*** 
 Less than monthly 0.91 (0.46, 1.83) 0.86 (0.35, 2.12) 2.14 (1.15, 3.99) 2.23 (1.07, 4.64) 
 Monthly or more 1.37 (0.64, 2.93) 1.53 (0.65, 3.63) 3.78 (1.96, 7.30) 5.87 (2.97, 11.57) 
Ever used other No 1 1 1 1** 
illicit drug Yes 2.32 (0.76, 7.08) 0.82 (0.27, 2.45) 1.43 (0.60, 3.39) 3.57 (1.42, 8.97) 
Survey year B-CAMHS99 1 1* 1** 1 
 B-CAMHS04 0.99 (0.75, 1.30) 0.71 (0.53, 0.96) 0.58 (0.42, 0.79) 1.08 (0.70, 1.67) 
Country England 1 1 1 1 
 Scotland 0.91 (0.57, 1.45) 0.69 (0.41, 1.16) 0.96 (0.62, 1.48) 0.79 (0.40, 1.57) 
 Wales 1.17 (0.69, 1.97) 0.49 (0.15, 1.58) 0.76 (0.29, 1.97) 1.15 (0.42, 3.13) 
Ethnic group White 1* 1** 1 1 
 Black 0.10 (0.01, 0.74) 0.14 (0.02, 1.11) 1.43 (0.50, 4.09) 0.48 (0.05, 4.45) 
 Indian† 0.17 (0.02, 1.45)  0.60 (0.12, 3.03)  
 Pakistani or 
Bangladeshi† 0.69 (0.16, 2.88)  0.18 (0.02, 1.78)  
 Other 0.61 (0.25, 1.48) 0.18 (0.05, 0.62) 0.89 (0.36, 2.21) 0.78 (0.30, 2.03) 
Good general 
health 
Change per level 
0.96 (0.80, 1.15) 1.13 (0.88, 1.46) 1.11 (0.87, 1.43) 1.14 (0.85, 1.52) 
Parent mental 
health 
Change per point 
1.03 (0.99, 1.07) 1.00 (0.95, 1.05) 0.99 (0.94, 1.04) 1.02 (0.95, 1.08) 
Family type Two-parent  1*** 1 1 1 
 Lone parent  1.91 (1.33, 2.76) 1.16 (0.75, 1.81) 1.51 (0.99, 2.29) 1.27 (0.79, 2.05) 
 Step family 1.94 (1.43, 2.63) 1.08 (0.73, 1.60) 1.16 (0.79, 1.69) 1.16 (0.72, 1.85) 
Parent’s highest No qualifications 1 1 1 1 
educational GCSEs 0.97 (0.70, 1.33) 1.11 (0.73, 1.66) 1.02 (0.69, 1.50) 0.86 (0.53, 1.41) 
level A-levels/diploma 0.84 (0.59, 1.20) 1.15 (0.73, 1.82) 1.15 (0.74, 1.80) 0.83 (0.46, 1.48) 
 Degree 0.75 (0.48, 1.18) 1.31 (0.79, 2.19) 1.47 (0.90, 2.38) 1.19 (0.63, 2.25) 
Housing tenure Owner occupied 1 1** 1 1 
 Rented 1.14 (0.84, 1.55) 0.49 (0.31, 0.78) 1.05 (0.74, 1.49) 0.74 (0.44, 1.24) 
OR = odds ratio.  † No Indian, Pakistani or Bangladeshi youth reported frequent alcohol use or other illicit drug 
use at follow-up, and these groups were therefore combined with youth of Other ethnicity when fitting 
multivariable models. 
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Table 9: Predicting to Mental health at follow-up, using parent SDQ scores: full results 
  Internalizing SDQ 
subscale (regression 
coefficient & 95%CI) 
Externalizing SDQ 
subscale (regression 
coefficient & 95%CI)  
Gender Male 0*** 0* 
 Female 0.64 (0.45, 0.82) -0.20 (-0.37, -0.02) 
Age at baseline 11 to 12 years 0 0*** 
 13 to 14 years 0.11 (-0.08, 0.30) -0.18 (-0.39, 0.02) 
 15 to 16 years 0.10 (-0.12, 0.33) -0.43 (-0.66, -0.20) 
Internalizing SDQ 
subscale 
Change per SDQ 
point 0.47 (0.43, 0.51)*** 0.03 (-0.01, 0.06) 
Externalizing SDQ 
subscale 
Change per SDQ 
point 0.07 (0.04, 0.10)*** 0.62 (0.58, 0.65)*** 
Smoking Never 0 0 
 Ex-smoker -0.13 (-0.50, 0.24) 0.15 (-0.36, 0.65) 
 Occasional  0.04 (-0.39, 0.47) -0.16 (-0.75, 0.44) 
 Regular smoker -0.17 (-0.67, 0.33) -0.01 (-0.64, 0.61) 
Frequent alcohol No 0 0 
consumption Yes -0.15 (-0.41, 0.12) 0.16 (-0.18, 0.50) 
Cannabis use  Never 0 0 
 Less than monthly 0.31 (-0.20, 0.82) -0.08 (-0.69, 0.54) 
 Monthly or more 0.32 (-0.36, 1.00) -0.26 (-1.10, 0.59) 
Ever used other No 0* 0 
illicit drug Yes 1.12 (0.04, 2.21) 0.43 (-0.89, 1.75) 
Survey year B-CAMHS99 0 0*** 
 B-CAMHS04 0.17 (-0.02, 0.35) 0.59 (0.39, 0.79) 
Country England 0 0 
 Scotland -0.12 (-0.40, 0.16) -0.01 (-0.31, 0.29) 
 Wales -0.14 (-0.60, 0.32) 0.00 (-0.55, 0.55) 
Ethnic group White 0 0 
 Black -0.32 (-0.84, 0.20) -0.20 (-0.86, 0.46) 
 Indian 0.12 (-0.57, 0.81) -0.09 (-0.61, 0.42) 
 Pakistani or 
Bangladeshi 0.84 (-0.01, 1.68) 0.25 (-0.88, 1.37) 
 Other -0.07 (-0.52, 0.38) 0.10 (-0.51, 0.72) 
Good general health Change per level -0.33 (-0.51, -0.15)*** -0.06 (-0.22, 0.11) 
Parent mental health Change per point 0.06 (0.02, 0.10)** 0.03 (-0.01, 0.07) 
Family type Two-parent  0 0 
 Lone parent  0.13 (-0.16, 0.42) 0.23 (-0.08, 0.54) 
 Step family -0.12 (-0.36, 0.12) 0.12 (-0.14, 0.38) 
Parent’s highest No qualifications 0 0* 
educational GCSEs -0.24 (-0.50, 0.02) -0.34 (-0.63, -0.04) 
level A-levels/diploma -0.38 (-0.68, -0.09) -0.41 (-0.71, -0.10) 
 Degree -0.17 (-0.49, 0.15) -0.51 (-0.85, -0.18) 
Housing tenure Owner occupied 0 0 
 Rented 0.23 (-0.02, 0.48) 0.15 (-0.12, 0.43) 
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Table 10: Predicting to Mental health at follow-up, using clinical diagnoses: full 
results 
  Emotional disorder 
(OR & 95%CI) 
Behavioral disorder 
(OR & 95%CI) 
Gender Male 1*** 1 
 Female 2.09 (1.49, 2.93) 0.83 (0.57, 1.22) 
Age at baseline 11 to 12 years 1* 1** 
 13 to 14 years 1.74 (1.18, 2.57) 0.57 (0.37, 0.89) 
 15 to 16 years 1.61 (1.00, 2.59) 0.43 (0.24, 0.77) 
Emotional No 1*** 1 
disorder Yes 4.98 (3.21, 7.72) 1.66 (0.94, 2.92) 
Behavioral No 1* 1*** 
disorder Yes 1.97 (1.07, 3.61) 11.82 (7.07, 19.73) 
Hyperactivity No 1 1* 
disorder Yes 0.87 (0.32, 2.36) 2.60 (1.20, 5.65) 
Smoking Never 1 1 
 Ex-smoker 0.88 (0.43, 1.79) 1.84 (0.88, 3.83) 
 Occasional  1.18 (0.49, 2.84) 1.74 (0.60, 5.08) 
 Regular smoker 0.77 (0.36, 1.64) 0.83 (0.32, 2.14) 
Frequent alcohol No 1 1 
consumption Yes 1.40 (0.85, 2.31) 1.06 (0.55, 2.05) 
Cannabis use  Never 1 1 
 Less than monthly 0.75 (0.30, 1.92) 1.26 (0.38, 4.16) 
 Monthly or more 1.00 (0.37, 2.67) 0.65 (0.17, 2.52) 
Ever used other No 1* 1 
illicit drug Yes 4.06 (1.31, 12.56) 1.31 (0.26, 6.65) 
Survey year B-CAMHS99 1 1* 
 B-CAMHS04 1.10 (0.76, 1.60) 0.66 (0.45, 0.99) 
Country England 1 1 
 Scotland 0.87 (0.51, 1.51) 0.73 (0.36, 1.47) 
 Wales 0.81 (0.33, 1.95) 0.43 (0.14, 1.37) 
Ethnic group White 1 1 
 Black 1.43 (0.48, 4.24) 0.43 (0.10, 1.80) 
 Indian 0.61 (0.12, 3.18) 0.57 (0.06, 5.08) 
 Pakistani or 
Bangladeshi 1.18 (0.39, 3.64) 1.21 (0.17, 8.60) 
 Other 1.09 (0.40, 2.95) 1.52 (0.62, 3.72) 
Good general health Change per level 0.64 (0.51, 0.80)*** 0.74 (0.59, 0.93)* 
Parent mental health Change per point 1.11 (1.06, 1.17)*** 1.02 (0.96, 1.08) 
Family type Two-parent  1 1 
 Lone parent  1.16 (0.70, 1.92) 1.23 (0.73, 2.06) 
 Step family 1.25 (0.80, 1.95) 1.18 (0.74, 1.89) 
Parent’s highest No qualifications 1 1 
educational GCSEs 1.14 (0.71, 1.82) 0.83 (0.52, 1.32) 
level A-levels/diploma 1.01 (0.60, 1.71) 0.74 (0.42, 1.29) 
 Degree 1.16 (0.61, 2.20) 0.83 (0.40, 1.73) 
Housing tenure Owner occupied 1 1** 
 Rented 1.05 (0.70, 1.57) 1.80 (1.20, 2.71) 
OR = odds ratio.  Results not presented for hyperactivity at follow-up because very high collinearity with 
hyperactivity at baseline led to very unstable estimates. 
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Table 11: Comparison of the predictors of regularly smoking and cannabis use at 
follow-up with lifetime smoking or cannabis use (adjusting for substance use at 
baseline): N=3607 
   Regular 
smoker (OR 
and 95% CI) 
Lifetime smoking 
(OR and 95% CI) 
Regular cannabis 
use (OR and 95% 
CI) 
Lifetime cannabis 
use (OR and 95% 
CI) 
Analyses 
using the 
Internalizing SDQ 
subscale 
Change per 
SDQ point 0.98 (0.94, 1.02) 0.97 (0.94, 1.00) 0.97 (0.92, 1.02) 0.95 (0.92, 0.99)* 
Parent SDQ Externalizing SDQ 
subscale 
Change per 
SDQ point 
1.14 (1.10, 
1.17)*** 
1.12 (1.09, 
1.15)*** 1.08 (1.03, 1.13)** 
1.07 (1.04, 
1.11)*** 
       
Analyses 
using the 
Internalizing 
DAWBA band 
Change per 
level 1.08 (0.91, 1.28) 1.02 (0.89, 1.17) 1.02 (0.82, 1.28) 1.04 (0.90, 1.20) 
DAWBA 
probability 
bands 
Behavioral 
DAWBA band 
Change per 
level 1.48 (1.23, 
1.78)*** 
1.48 (1.28, 
1.72)*** 1.37 (1.12, 1.68)** 1.30 (1.12, 1.49) 
 Hyperactivity 
DAWBA band 
Change per 
level 1.16 (0.93, 1.44) 1.04 (0.88, 1.24) 0.92 (0.73, 1.18) 
0.91 (0.74, 
1.12)*** 
       
Analyses Internalizing No 1* 1* 1 1 
using  disorder Yes 1.65 (1.08, 2.52) 1.50 (1.02, 2.19) 1.01 (0.57, 1.81) 0.99 (0.65, 1.50) 
clinical Behavioral No 1*** 1** 1 1 
diagnoses disorder Yes 2.83 (1.72, 4.64) 2.29 (1.43, 3.66) 1.66 (0.97, 2.84) 1.52 (0.97, 2.38) 
 Hyperactivity No 1 1 1 1 
 disorder Yes 1.25 (0.55, 2.82) 1.51 (0.68, 3.35) 0.87 (0.37, 2.07) 0.76 (0.36, 1.61) 
OR = odds ratio.  All models adjust for gender; age; baseline smoking, alcohol use, cannabis use and other 
illicit drug use; survey year; country; ethnic group; parent education; housing tenure; family type.   
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Table 12: Effect of substance use at baseline upon mental health at follow-up, with 
stratification by disorder presence/absence at baseline 
 
Internalizing 
disorder 
 
 Odds ratio and 
95% CI 
   
  Full sample Internalising 
baseline disorder 
present (disorder 
persistence) 
Internalising 
baseline disorder 
absent (incident 
cases) 
P-value for 
interaction with 
baseline internalizing 
disorder status 
N cases  3607 244 3363  
Smoking Never 1 1 1 0.50 
 Ex-smoker 0.88 (0.43, 1.79) 0.34 (0.04, 3.15) 0.98 (0.45, 2.14)  
 Occasional 1.18 (0.49, 2.84) 0.43 (0.09, 2.14) 1.43 (0.53, 3.82)  
 Regular smoker 0.77 (0.36, 1.64) 1.16 (0.26, 5.25) 0.74 (0.30, 1.87)  
Frequent 
alcohol 
No 
1 1 1 0.64 
consumption Yes 1.40 (0.85, 2.31) 2.01 (0.18, 22.06) 1.24 (0.66, 2.33)  
Cannabis use  Never 1 1 1 0.62 
 Less than monthly 0.75 (0.30, 1.92) 0.36 (0.06, 2.00) 0.78 (0.25, 2.40)  
 Monthly or more 1.00 (0.37, 2.67) 0.85 (0.04, 17.36) 0.99 (0.28, 3.50)  
Ever used 
other 
No 
1* 1 1** 0.17 
illicit drug Yes 4.06 (1.31, 12.56) 1.36 (0.15, 12.07) 5.72 (1.60, 20.48)  
      
Behavioral 
disorder 
 Odds ratio and 
95% CI 
   
  Full sample Externalising 
baseline disorder 
present (disorder 
persistence) 
Externalising 
baseline disorder 
absent (incident 
cases) 
P-value for 
interaction with 
baseline externalizing 
disorder status 
N cases  3607 235 3372  
Smoking Never 1 1 1 0.64 
 Ex-smoker 1.84 (0.88, 3.83) 1.21 (0.21, 6.80) 2.12 (0.88, 5.09)  
 Occasional 1.74 (0.60, 5.08) 1.78 (0.10, 30.98) 1.58 (0.43, 5.75)  
 Regular smoker 0.83 (0.32, 2.14) 1.15 (0.28, 4.67) 0.81 (0.15, 4.50)  
Frequent 
alcohol 
No 
1 1 1 0.72 
consumption Yes 1.06 (0.55, 2.05) 0.68 (0.11, 4.11) 1.15 (0.51, 2.56)  
Cannabis use  Never 1 1 1 0.61 
 Less than monthly 1.26 (0.38, 4.16) 0.84 (0.06, 11.08) 1.58 (0.37, 6.84)  
 Monthly or more 0.65 (0.17, 2.52) 0.53 (0.09, 2.96) 0.62 (0.07, 5.46)  
Ever used 
other 
No 
1 1 1 0.36 
illicit drug Yes 1.31 (0.26, 6.65) 1.24 (0.13, 11.83) 1.99 (0.20, 19.62)  
Odds ratio calculated using logistic regression.  All models adjust for gender; age; baseline internalizing 
and externalizing mental health disorder. 
 
 
